A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy
NCT ID: NCT06661174
Last Updated: 2024-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2023-10-01
2025-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
the Related Factors of Bariatric Surgery on Glomerular Filtration Rate
NCT03689777
The Effect of Bariatric/Metabolic Surgery on GFR
NCT02406664
The Effect of Bariatric Surgery on Glucose Metabolism
NCT04174768
Effect of Bariatric Surgery on Blood Pressure
NCT02050984
Development of Obesity and Bariatric Surgery
NCT03296605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical group
Bariatric surgery
Laparoscopic sleeve gastrectomy or laparoscopic gastric bypass based on β-cell function
Non-surgical therapy
Diet management，exercise，metformin，GLP-1 receptor agonists and other drugs which can lose weight.
Non-surgical group
Non-surgical therapy
Diet management，exercise，metformin，GLP-1 receptor agonists and other drugs which can lose weight.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bariatric surgery
Laparoscopic sleeve gastrectomy or laparoscopic gastric bypass based on β-cell function
Non-surgical therapy
Diet management，exercise，metformin，GLP-1 receptor agonists and other drugs which can lose weight.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI\>25Kg/m2 or abdominal obesity (i.e. waist circumference\>90cm for men and\>85cm for women);
* eGFR\<30ml/min/1.73m2 or urinary microalbumin≥300mg/g, eGFR\<60ml/min/1.73m2.
Exclusion Criteria
* Combined with tumors; ③Combined with autoimmune diseases; ④Serum albumin\<25g/L.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China-Japan Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hua Meng
Director of the General Surgery Department & Obesity and Metabolic Disease Center of China-Japan Friendship Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hua Meng
Role: PRINCIPAL_INVESTIGATOR
China-Japan Friendship Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EBSDKD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.